JPRN-UMIN000025943已完成未知
ong-term Safety of treatment with tocilizumab in the refractory patients with Takayasu Arteritis - Long-term ACTemra Investigation for remissION introduction in TAKayasu Arteritits (LACTION-TAK)
Osaka Unversity0 个研究点目标入组 9 人开始时间: 2017年2月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 60years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have a labeled contraindication or a careful administration to tocilizumab 2)Patients who are currently participating in clinical trial studies of other investigational new drugs or devices 3)Patients who are currently participating in other clinical studies 4)Patients who are pregnant, breast-feeding or have possibilities for pregnancy 5)Patients within 6 months of onset of acute myocardial infaraction or cerebrovascular disease 6)Patients who undergoes dialysis treatment 7)Patients with advanced hepatic dysfunction (AST more than 100 IU/l or ALT more than 100 IU/l) 8)Patients who are hepatitis B virus carriers 9)Patients expected to live less than 12 months due to a complicating disease 10)Patients that researchers (cardiologists) evaluated unsuitable for participating in this clinical trial 11)Patients who have the history of gastrointestinal bleeding due to the inflammatory bowel diseases
研究者
相似试验
已完成
不适用
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000007845Department of Cardiovascular Medicine Graduate School of Medicine Osaka University15
已完成
不适用
Efficacy and safety of tocilizumab monotherapy in patients with microscopic polyangiitisMicroscopic polyangiitisJPRN-UMIN000011242Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology10
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with large vessel vasculitis (LVV; giant cell arteritis or Takayasu arteritis) and polymyalgia rheumatica (PMR)Rheumatoid arthritisJPRN-UMIN000008812Department of Rheumatology & Clinical Immunology Saitama Medical Center, Saitama Medical Universitity40
已完成
不适用
Efficacy and safety of tocilizumab mono-therapy in patients with adult-onset Still's diseaseRheumatoid arthritisJPRN-UMIN000007019Department of Rheumatology & Clinical Immunology,Saitama Medical Center, Saitama Medical Universitity40
招募中
2 期
Evaluation the Efficacy and Safety of Tocilizumab in COVID-19COVID-19 pneumonia.Confirmed diagnosis of COVID-19RA01.0IRCT20151227025726N13Shahid Beheshti University of Medical Sciences40